Pfizer’s Bourla: There’s Coronavirus Vaccine Pressure, But It’s Not Political

Pfizer Inc. CEO Albert Bourla said he doesn’t worry about political pressure to bring potentially the first coronavirus vaccine to market, but can’t escape feeling the weight of the world on... Read more »

Drug Review Times Not Shortened Much by Single Expedited Review Designation

Expedited programs usually shorten a US Food and Drug Administration new drug application assessment, but on average, maybe not as much as their reputation would suggest.

A Government Accountability Office (GAO) ... Read more »